2-hydroxyimipramine has been researched along with alfuzosin in 1 studies
Studies (2-hydroxyimipramine) | Trials (2-hydroxyimipramine) | Recent Studies (post-2010) (2-hydroxyimipramine) | Studies (alfuzosin) | Trials (alfuzosin) | Recent Studies (post-2010) (alfuzosin) |
---|---|---|---|---|---|
30 | 3 | 0 | 427 | 127 | 120 |
Protein | Taxonomy | 2-hydroxyimipramine (IC50) | alfuzosin (IC50) |
---|---|---|---|
Acetylcholinesterase | Homo sapiens (human) | 0.018 | |
Alpha-1D adrenergic receptor | Homo sapiens (human) | 0.023 | |
Alpha-1A adrenergic receptor | Homo sapiens (human) | 0.023 | |
Alpha-1B adrenergic receptor | Homo sapiens (human) | 0.023 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
1 other study(ies) available for 2-hydroxyimipramine and alfuzosin
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |